New Key Statistics Module, Z-Score and F-Score
NAS:AMRX Key Ratios
| Market Cap $ M | 2,064.88 |
| Enterprise Value $ M | 4,801.23 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 10.14 |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.55 |
| Price/Free Cash Flow | 11.02 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,495.00 |
| EPS (TTM) $ | -0.56 |
| Beneish M-Score | -2.7 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 19.30 |
| y-y EBITDA Growth Rate % | 81.40 |
| EV-to-EBIT | 39.79 |
| EV-to-EBITDA | 13.82 |
| PEG | 0.53 |
| Shares Outstanding M | 308.65 |
| Net Margin (%) | -6.76 |
| Operating Margin % | 10.84 |
| Pre-tax Margin (%) | -4.26 |
| Quick Ratio | 0.97 |
| Current Ratio | 1.65 |
| ROA % (ttm) | -4.70 |
| ROE % (ttm) | -93.77 |
| ROIC % (ttm) | 10.21 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.15 |
AMRX Number of Guru Trades
AMRX Volume of Guru Trades
Gurus Latest Trades with NAS:AMRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AMRX is held by these investors
Total 2
Amneal Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AMRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers